L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.
暂无分享,去创建一个
D. Kass | L. Becker | J. Hare | S. Schulman | G. Gerstenblith | H. Champion | M. Terrin | S. Forman | M. Kelemen | S. Townsend | Kavita V Ernst | A. Capriotti
[1] E. Lakatta,et al. Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults , 2005, Circulation.
[2] D. Kass,et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. , 2005, The Journal of clinical investigation.
[3] R. Böger,et al. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor. , 2005, Alternative medicine review : a journal of clinical therapeutic.
[4] D. Reed-Gillette,et al. Prevalence of leading types of dietary supplements used in the Third National Health and Nutrition Examination Survey, 1988--94. , 2004, Advance data.
[5] D. Kass,et al. Age and gender affect ventricular-vascular coupling during aerobic exercise. , 2004, Journal of the American College of Cardiology.
[6] R. Jacob,et al. Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress , 2004, Circulation.
[7] A. Shoukas,et al. Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels , 2003, Circulation.
[8] J. Hochman,et al. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. , 2003, Circulation.
[9] R. Ferrante,et al. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] Daniel Levy,et al. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. , 2003, Circulation.
[11] Daniel Levy,et al. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. , 2003, Circulation.
[12] J. Astern,et al. Effects of Chronic Treatment With l-Arginine on Atherosclerosis in ApoE Knockout and ApoE/Inducible NO Synthase Double-Knockout Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[13] V. Berger. Improving the information content of categorical clinical trial endpoints. , 2002, Controlled clinical trials.
[14] David J. Webb,et al. Nitric Oxide Regulates Local Arterial Distensibility In Vivo , 2002, Circulation.
[15] R. Cannon. Oral L-arginine (and other active ingredients) for ischemic heart disease?. , 2002, Journal of the American College of Cardiology.
[16] Judy W. M. Cheng,et al. L-Arginine in the Management of Cardiovascular Diseases , 2001, The Annals of pharmacotherapy.
[17] R. Cannon,et al. Oral L-arginine in patients with coronary artery disease on medical management. , 2000, Circulation.
[18] J. Loscalzo. What we know and don't know about L-arginine and NO. , 2000, Circulation.
[19] J. Lachin. Worst-rank score analysis with informatively missing observations in clinical trials. , 1999, Controlled clinical trials.
[20] P. Tsao,et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. , 1998, Circulation.
[21] B. Fetics,et al. Estimation of Central Aortic Pressure Waveform by Mathematical Transformation of Radial Tonometry Pressure Data , 1998 .
[22] S. Higano,et al. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. , 1998, Circulation.
[23] L A Moyé,et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. , 1997, Circulation.
[24] J. Cooke,et al. Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases. , 1997, Circulation.
[25] D. Levy,et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. , 1997, Circulation.
[26] C. H. Chen,et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. , 1997, Circulation.
[27] D. Celermajer,et al. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. , 1997, Atherosclerosis.
[28] M. Petch,et al. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. , 1996, Journal of the American College of Cardiology.
[29] K. Lee,et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. , 1996, Circulation.
[30] T. Rector,et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. , 1996, Circulation.
[31] A. Keech,et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. , 1996, The Journal of clinical investigation.
[32] G. B. John Mancini,et al. Angiotensin Converting Enzyme Inhibition, with Quinapril, Improves Endothelial Vasomotor Dysfunction in Patients with Coronary Artery Disease: the TREND Study (Trial on REversing ENdothelial Dysfunction) , 1996 .
[33] T. Lüscher,et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. , 1996, Circulation.
[34] R. Wilson,et al. Direct effects of smooth muscle relaxation and contraction on in vivo human brachial artery elastic properties. , 1995, Circulation research.
[35] E. McVeigh,et al. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction. , 1995, The American journal of cardiology.
[36] L. Ghiadoni,et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. , 1995, Circulation.
[37] D. Spiegelhalter,et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.
[38] J. F. Burke,et al. The plasma flux and oxidation rate of ornithine adaptively decline with restricted arginine intake. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] B. Chaitman,et al. Impact of Age on Clinical Outcome and Postlytic Management Strategies in Patients Treated With Intravenous Thrombolytic Therapy: Results From the TIMI II Study , 1994, Circulation.
[40] F. Harrell,et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. , 1994, Circulation.
[41] G. Lamas,et al. Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril , 1994, Circulation.
[42] M. Yokota,et al. Relation between ventriculoarterial coupling and myocardial energetics in patients with idiopathic dilated cardiomyopathy. , 1994, Journal of the American College of Cardiology.
[43] A. Maseri,et al. Age-Related Increase in Mortality among Patients with First Myocardial Infarctions Treated with Thrombolysis , 1993 .
[44] David A. Kass,et al. Effective Arterial Elastance as Index of Arterial Vascular Load in Humans , 1992, Circulation.
[45] M. Pfeffer,et al. Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.
[46] S. Moncada,et al. EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.
[47] S Sasayama,et al. Ventriculoarterial coupling in normal and failing heart in humans. , 1989, Circulation research.
[48] F. Yin,et al. Aortic Compliance in Human Hypertension , 1989, Hypertension.
[49] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[50] A P Avolio,et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. , 1985, Circulation.
[51] JosephLoscalzo. Adverse Effects of Supplemental l-Arginine in Atherosclerosis , 2003 .
[52] D. Kereiakes,et al. Endothelial dysfunction. , 2003, Circulation.
[53] S. Bode-Böger,et al. The clinical pharmacology of L-arginine. , 2001, Annual review of pharmacology and toxicology.
[54] H. Drexler,et al. Endothelial dysfunction: clinical implications. , 1997, Progress in cardiovascular diseases.
[55] P. López-Jaramillo,et al. The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.
[56] S. Morris,et al. Regulation of enzymes of urea and arginine synthesis. , 1992, Annual review of nutrition.